Four studies (Winston et al., 2016, 2018; Guix et al., 2018; Gu et al., 2020) reported that the levels of p-T181-tau and p-S396-tau showed no significant difference between AD and pre-clinical AD/HC or pre-clinical AD and HC. Here, MAPT is linked to Alzheimer disease.